[ad_1]
Today, Tuesday, German pharmaceutical company Biontec announced that it and its partner, US company Fayez, have reached agreements with many countries and the European Union to provide 570 million doses this year and year. next, the Corona vaccine that the two companies are working to develop.
The company, based in the city of Mainz in western Germany, said all deals are contingent on the clinical success of the vaccine and on obtaining a permit.
Earlier, Biontec announced encouraging progress on the vaccine’s effectiveness and said it was likely to request, in partnership with Pfizer, from the middle of next week, to request the US Food and Drug Administration. – United to obtain permission to circulate the vaccine.
Biontech said that in addition to the European Union, it has jointly entered into supply agreements with Pfizer with the United States, Canada and Japan.
Referring to the interim results achieved by the two companies, which indicated that the vaccine will provide more than 90% effectiveness in the fight against Corona, Ujur Sahin, CEO of Biontech and one of its founders, said this morning that this that happened is a “turning point, whether for our company or for innovation in the scientific field”, These data bring us closer to a potential solution to the current global pandemic. “
Based on the supply forecast, Biontech said it plans to deliver up to 500 doses of the vaccine this year and produce up to 1.3 billion doses next year.
The company’s plant in Marburg, eastern Germany, plays an important role in production, and Biontech finalized the acquisition of the plant from Swiss company Novartis last month.
Follow the global news of the declaration via Google News
Source link
